# Viper's Bugloss (Echium vulgare)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/viper-s-bugloss
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-24
**Evidence Score:** 2 / 10
**Category:** Herb
**Also Known As:** Echium vulgare, Blueweed, Blue Devil, Blue Thistle, Snake Flower, Viper's Herb, Viper's Grass, Common Viper's Bugloss

## Overview

Viper's bugloss (Echium vulgare) contains phenolic compounds including rosmarinic acid and caffeic acid that demonstrate [antioxidant](/ingredients/condition/antioxidant) properties in laboratory studies. The plant has traditional uses for wound healing and [inflammation](/ingredients/condition/inflammation), though clinical evidence remains limited to preliminary phytochemical research.

## Health Benefits

• Traditional wound healing and [anti-inflammatory](/ingredients/condition/inflammation) support (preliminary evidence from phytochemical studies only)
• [Antioxidant activity](/ingredients/condition/antioxidant) via phenolic compounds like rosmarinic and caffeic acid (in vitro evidence only)
• Traditional use for muscle strains and sprains (ethnobotanical documentation, no clinical validation)
• Historical application for skin disorders and ulcers (traditional use only, no human trials)
• Potential [antimicrobial](/ingredients/condition/immune-support) properties linked to naphthoquinones (inferred from related species, not clinically proven)

## Mechanism of Action

Rosmarinic acid and caffeic acid in Viper's bugloss exhibit [antioxidant activity](/ingredients/condition/antioxidant) by scavenging free radicals and inhibiting lipid peroxidation pathways. These phenolic compounds may modulate [inflammatory](/ingredients/condition/inflammation) responses through inhibition of cyclooxygenase and lipoxygenase enzymes. The traditional wound healing effects may involve enhanced [collagen synthesis](/ingredients/condition/skin-health) and [antimicrobial](/ingredients/condition/immune-support) activity.

## Clinical Summary

Current evidence for Viper's bugloss is limited to in vitro phytochemical studies demonstrating [antioxidant activity](/ingredients/condition/antioxidant) of isolated compounds. No randomized controlled trials have evaluated safety or efficacy in humans. Traditional ethnobotanical documentation supports historical use for topical wound healing and muscle strain relief. Clinical research is needed to validate these traditional applications and establish appropriate dosing protocols.

## Nutritional Profile

Viper's Bugloss (Echium vulgare) contains a complex array of phytochemicals and nutrients. Key bioactive compounds include pyrrolizidine alkaloids (echimidine, lycopsamine, intermedine; total alkaloid content approximately 0.3–1.2% dry weight in aerial parts — notable hepatotoxic concern affecting bioavailability safety profile). Phenolic acids include rosmarinic acid (estimated 0.5–2 mg/g dry weight) and caffeic acid derivatives (0.2–1 mg/g dry weight), which are moderately bioavailable via intestinal absorption. Flavonoids including quercetin and kaempferol glycosides are present at approximately 0.1–0.8 mg/g dry weight, with bioavailability enhanced by gut microbial deglycosylation. Seeds are notably rich in gamma-linolenic acid (GLA, approximately 8–12% of seed oil) and stearidonic acid (SDA, approximately 4–6% of seed oil), offering a favorable omega-6/omega-3 fatty acid profile; lipid bioavailability is high (~85–90%). Seed oil also contains alpha-linolenic acid (~30–40% of fatty acids). Tannins (condensed and hydrolysable, ~1–3% dry weight) reduce mineral bioavailability via chelation. Mineral content includes calcium (~800–1200 mg/100g dry herb), potassium (~1500–2500 mg/100g), magnesium (~150–300 mg/100g), and iron (~10–25 mg/100g), though bioavailability of iron and calcium is limited by tannin and oxalate interactions. Vitamin C is present in fresh plant material (~20–50 mg/100g fresh weight) but degrades significantly with drying. Mucilaginous polysaccharides contribute to the plant's traditional demulcent properties. Caution: pyrrolizidine alkaloid content substantially limits safe internal use; bioavailability of beneficial compounds must be weighed against hepatotoxic alkaloid absorption.

## Dosage & Preparation

No clinically studied dosages exist for E. vulgare. Related Echium species used 2g/day aqueous extract in trials. Traditional preparations include decoctions, infusions, and topical ointments without quantified doses. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Viper's bugloss contains pyrrolizidine alkaloids that may cause hepatotoxicity with prolonged use or high doses. Pregnant and breastfeeding women should avoid use due to potential liver toxicity and lack of safety data. The plant may interact with medications metabolized by liver enzymes due to its alkaloid content. Topical use may cause contact dermatitis in sensitive individuals.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Echium vulgare were identified. Related species show limited evidence: one RCT (PMID: 40255949) tested E. amoenum combined with fennel for PMS in 80 women, while another (PMID: 24250495) examined E. amoenum with SSRIs for anxiety in 37 adults. Sources emphasize the urgent need for E. vulgare-specific clinical validation.

## Historical & Cultural Context

E. vulgare has centuries of use in European, Mediterranean, African, and Asian folk medicine for wound healing, snakebites, blood purification, and respiratory ailments. Ethnobotanical surveys from Turkey, Serbia, and Morocco document continuous use through the 20th century, with preparations ranging from internal decoctions to external poultices.

## Synergistic Combinations

Calendula officinalis, Centella asiatica, Aloe vera, Symphytum officinale, Plantago major

## Frequently Asked Questions

### What compounds in viper's bugloss provide antioxidant effects?

Rosmarinic acid and caffeic acid are the primary phenolic compounds responsible for viper's bugloss antioxidant activity. These compounds have demonstrated free radical scavenging properties in laboratory studies, though human clinical data is lacking.

### Is viper's bugloss safe for long-term use?

Viper's bugloss contains pyrrolizidine alkaloids that may cause liver toxicity with prolonged use. Long-term consumption is not recommended due to potential hepatotoxic effects and lack of safety studies in humans.

### How was viper's bugloss traditionally used for healing?

Traditional applications included topical use for wound healing, treating muscle strains and sprains, and anti-inflammatory purposes. However, these uses are based on ethnobotanical documentation rather than clinical evidence.

### Can viper's bugloss interact with medications?

Yes, viper's bugloss may interact with medications processed by liver enzymes due to its pyrrolizidine alkaloid content. Individuals taking prescription medications should consult healthcare providers before use.

### What is the difference between internal and topical viper's bugloss use?

Topical application may reduce exposure to hepatotoxic pyrrolizidine alkaloids compared to internal consumption. However, both applications lack clinical safety data and may cause adverse reactions in sensitive individuals.

### What is the difference between viper's bugloss seed oil and leaf extracts?

Viper's bugloss seed oil is rich in gamma-linolenic acid (GLA), an omega-6 polyunsaturated fatty acid with some preliminary research supporting anti-inflammatory effects, while leaf extracts contain higher concentrations of phenolic compounds like rosmarinic acid. The seed oil is typically used for systemic support, whereas leaf extracts are more commonly employed for topical or traditional wound-healing applications. Both forms lack robust clinical validation, though seed oil has comparatively more published research in human studies.

### Is viper's bugloss safe during pregnancy and breastfeeding?

There is insufficient clinical data on viper's bugloss safety during pregnancy and breastfeeding, so it is generally not recommended during these periods without medical supervision. Historical use does not establish safety in pregnant or nursing populations, and the presence of alkaloids in some Echium species raises theoretical concerns. Consult a healthcare provider before use if you are pregnant, planning pregnancy, or breastfeeding.

### How strong is the clinical evidence supporting viper's bugloss for inflammation and wound healing?

Current evidence for viper's bugloss is limited to in vitro phytochemical studies and traditional/ethnobotanical documentation—there are no large randomized controlled trials in humans demonstrating efficacy for wound healing or inflammation. While laboratory studies show antioxidant and anti-inflammatory compounds are present, this does not confirm therapeutic benefit in living organisms. More rigorous clinical research is needed before claims about inflammation or wound support can be considered scientifically validated.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*